Results 91 to 100 of about 77,789 (337)

Increased Fracture Risk with Furosemide Use in Children with Congenital Heart Disease

Jornal de Pediatria, 2018
Objectives To determine the association of furosemide therapy with the incidence of bone fractures in children with congenital heart disease. Study design We conducted a retrospective cohort study with data extracted from the 2008‐2014 Texas Medicaid ...
J. Heo, K. Rascati, Keila N. Lopez, B. Moffett   +3 more
semanticscholar   +1 more source

A study of the efficacy of furosemide as a prophylaxis of acute renal failure in coronary artery bypass grafting patients: A clinical trial

ARYA Atherosclerosis, 2015
BACKGROUND: Renal failure is a frequent event after coronary artery bypass grafting (CABG). Hemodynamic alterations during surgery as well as the underlying disease are the predisposing factors.
Fatemeh Bayat, Zahra Faritous, Nahid Aghdaei, Ali Dabbagh   +3 more
doaj  

Clinical Usefulness of Furosemide to Prevent Volume Overload Among Children and Young Adults with Transfusion-Dependent Thalassemia: A Randomized, Open-Label, Crossover Study

Journal of Blood Medicine, 2020
Apichat Photia,1 Chanchai Traivaree,1 Chalinee Monsereenusorn,1 Piyarat Simthamnimit,2 Piya Rujkijyanont1 1Division of Hematology-Oncology, Department of Pediatrics, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand; 2Department of ...
Photia A, Traivaree C, Monsereenusorn C, Simthamnimit P, Rujkijyanont P   +4 more
doaj  

Massive Proteinuria-Induced Injury of Tubular Epithelial Cells in Nephrotic Syndrome is Not Exacerbated by Furosemide

Cellular Physiology and Biochemistry, 2018
Background/Aims: Massive proteinuria, a significant sign of nephrotic syndrome (NS), has the potential to injure tubular epithelial cells (TECs). Furosemide is widely used for the treatment of edema, a common manifestation of NS.
Shujun Wang, Qingjun Pan, Chen Xu, Jun-jia Li, Hao-Xuan Tang, Ting Zou, Kai-peng Jing, Lin Ye, Hong-Luan Wu, Wei-jing Liu, Hua-feng Liu   +10 more
doaj   +1 more source

Inter-subject variability in oral drug absorption

, 2015
A low and highly variable bioavailability is often the main reason for the failure of the development of a drug intended for oral delivery. Focusing on absorption instead of bioavailability from oral administration enables the identification and ...
Rabbie, S
core  

Biorelevant characterisation of amorphous furosemide salt exhibits conversion to a furosemide hydrate during dissolution

, 2013
Biorelevant dissolution behaviour of the amorphous sodium salt and amorphous acid forms of furosemide was evaluated, together with investigations of the solid state changes during in vitro dissolution in medium simulating the conditions in the small ...
Gordon, Sarah, Østergaard, Jesper, Pajander, Jari Pekka, Müllertz, Anette, Gordon, Sarah; id_orcid, Nielsen, Line Hagner, Rades, Thomas   +6 more
core   +1 more source

On‐site pilot‐scale advanced oxidation pretreatment of hospital wastewater: assessment of pharmaceuticals, pathogens, antibiotic resistance genes and acute ecotoxicity

Journal of Chemical Technology &Biotechnology, EarlyView.
Abstract BACKGROUND Hospital premises generate wastewater containing a wide spectrum of contaminants, such as pharmaceutically active compounds (PhACs), antibiotic resistance genes (ARGs) and pathogenic microorganisms, whilst plenty of them are classified under the antibiotic resistant bacteria (ΑRΒ) category.
Andreas Kaliakatsos, Iosifina Gounaki, Spyros Dokianakis, Georgios Gkotsis, Maria‐Christina Nika, Eleni Aleiferi, Athanasios S Stasinakis, Nikos Katsarakis, Nikolaos S Thomaidis, Thrassyvoulos Manios, Michalis S Fountoulakis, Danae Venieri   +11 more
wiley   +1 more source

Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study

Journal of Veterinary Internal Medicine, 2020
Background Torasemide is a potent loop diuretic with potential to treat congestive heart failure (CHF) in dogs. Objective Evaluate the efficacy and safety of torasemide compared to furosemide in dogs with first occurrence of CHF caused by degenerative ...
Beatrice Besche, Thomas Blondel, Emilie Guillot, Catherine Garelli‐Paar, Mark A. Oyama   +4 more
doaj   +1 more source

New-Onset Acute Heart Failure With Reduced Ejection Fraction Associated With Severe Microcytic Anemia. [PDF]

Clin Case Rep
Graphical abstract summarizing a case of new‐onset HFrEF associated with profound microcytic anemia, highlighting severe anemia as a potential reversible trigger of acute cardiac decompensation. ABSTRACT Severe microcytic anemia may serve as a potentially reversible precipitating factor in heart failure with reduced ejection fraction (HFrEF). This case
Ricci A, Hunt C, Gomez C, Santafe G, Gonzalez A, Duarte M.   +5 more
europepmc   +2 more sources

Resource management and clinical outcomes during a national intravenous fluid shortage

Journal of Hospital Medicine, EarlyView.
Abstract Background A natural disaster, Hurricane Helene, damaged a production facility supplying 60% of intravenous (IV) fluids in the United States. A nationwide IV fluid shortage followed. Objectives To evaluate a multifaceted IV fluid conservation intervention's effect on IV fluid utilization and clinical outcomes during the shortage.
Stacy A. Johnson, Erin R. Fox, Smitha Warrier, Russell Vinik   +3 more
wiley   +1 more source